Raymond James Financial Services Advisors’s Apyx Medical APYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$107K Buy
86,609
+2,086
+2% +$2.59K ﹤0.01% 3273
2024
Q2
$113K Sell
84,523
-200
-0.2% -$268 ﹤0.01% 3208
2024
Q1
$115K Sell
84,723
-523,905
-86% -$713K ﹤0.01% 3197
2023
Q4
$1.59M Buy
608,628
+187,350
+44% +$491K ﹤0.01% 1694
2023
Q3
$1.35M Buy
421,278
+1,100
+0.3% +$3.52K ﹤0.01% 1742
2023
Q2
$2.11M Buy
420,178
+27,351
+7% +$138K ﹤0.01% 1481
2023
Q1
$1.13M Buy
392,827
+34,090
+10% +$98.2K ﹤0.01% 1827
2022
Q4
$839K Sell
358,737
-50,373
-12% -$118K ﹤0.01% 1948
2022
Q3
$1.84M Buy
409,110
+33,492
+9% +$150K ﹤0.01% 1463
2022
Q2
$2.2M Buy
375,618
+73,012
+24% +$428K ﹤0.01% 1383
2022
Q1
$1.98M Buy
302,606
+6,150
+2% +$40.2K ﹤0.01% 1496
2021
Q4
$3.8M Buy
296,456
+8,984
+3% +$115K 0.01% 1148
2021
Q3
$3.98M Buy
287,472
+7,069
+3% +$97.9K 0.01% 1095
2021
Q2
$2.89M Buy
280,403
+5,185
+2% +$53.5K 0.01% 1263
2021
Q1
$2.66M Buy
275,218
+10,663
+4% +$103K 0.01% 1235
2020
Q4
$1.91M Buy
264,555
+7,245
+3% +$52.2K ﹤0.01% 1327
2020
Q3
$1.21M Sell
257,310
-17,264
-6% -$81.3K ﹤0.01% 1434
2020
Q2
$1.52M Buy
274,574
+16,000
+6% +$88.8K ﹤0.01% 1239
2020
Q1
$928K Buy
258,574
+10,100
+4% +$36.2K ﹤0.01% 1238
2019
Q4
$2.1M Sell
248,474
-10,275
-4% -$86.9K 0.01% 1144
2019
Q3
$1.75M Buy
258,749
+13,314
+5% +$90.2K 0.01% 1177
2019
Q2
$1.65M Buy
245,435
+18,401
+8% +$124K 0.01% 1208
2019
Q1
$1.43M Buy
227,034
+3,300
+1% +$20.8K 0.01% 1248
2018
Q4
$1.45M Sell
223,734
-6,600
-3% -$42.8K 0.01% 1071
2018
Q3
$1.64M Buy
230,334
+82,984
+56% +$589K 0.01% 1191
2018
Q2
$641K Buy
147,350
+46,600
+46% +$203K ﹤0.01% 1698
2018
Q1
$299K Sell
100,750
-15,500
-13% -$46K ﹤0.01% 2030
2017
Q4
$302K Buy
116,250
+6,300
+6% +$16.4K ﹤0.01% 2014
2017
Q3
$372K Buy
109,950
+29,200
+36% +$98.8K ﹤0.01% 1899
2017
Q2
$199K Buy
+80,750
New +$199K ﹤0.01% 2233